Pharmalot By Ed Silverman Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
First Opinion By Mark Reisenauer Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible
Health Tech By Kate Sheridan and Casey Ross In a defamation lawsuit, the hype around digital health clashes with scientific criticism
Health By Andrew Joseph Supreme Court debates exactly when a doctor’s misprescribing becomes criminal
Pharmalot By Ed Silverman Tennessee judge sanctions Endo for withholding opioid documents, refuses to recuse himself from case
Biotech By Megan Molteni UC Berkeley loses CRISPR patent case, invalidating patent rights it granted gene-editing companies developing human therapies
Pharmalot By Ed Silverman Johnson & Johnson, three pharma wholesalers finalize $26 billion opioid crisis settlement
Health By Olivia Goldhill Vague ‘medical emergency’ exceptions in abortion laws leave pregnant people in danger, doctors say
Pharmalot By Ed Silverman Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons
Health By Olivia Goldhill Psychedelic medicine group investigating a board member accused of financial elder abuse
Pharmalot By Ed Silverman Greece plans to go to court to seek compensation from Novartis over a bribery scandal
Hospitals By Tara Bannow Advocate Aurora-Atrium’s mammoth merger: Experts split on whether federal regulators will challenge the deal
Pharmalot By Ed Silverman J&J sues a behind-the-scenes company for exploiting its patient assistance program
Pharmalot By Ed Silverman Pharmalittle: Investors reject proposals for Covid vaccine makers to share know-how; CMS head says Alzheimer’s drug decision is rare
Pharmalot By Ed Silverman Usual and customary? Rite Aid ordered to pay Humana $123 million for inflating pharmacy claims
A STAT Investigation By Olivia Goldhill A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens
Pharmalot By Ed Silverman Endo wins a reprieve in an opioid lawsuit in Tennessee as appeals court overturns sanctions
Pharmalot By Ed Silverman Louisiana accuses UnitedHealth and its OptumRx PBM of inflating drug costs for its Medicaid program
Pharmalot By Ed Silverman Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs
Politics By Nicholas Florko Will Biogen sue Medicare over its restrictions on the Alzheimer’s drug, Aduhelm? And other big legal questions about the decision
Pharmalot By Ed Silverman Pharma companies face shareholder proposals to widen access to medicines, rework business practices
Pharmalot By Ed Silverman HHS seeks to penalize another drugmaker amid legal clash over drug discount program
First Opinion By Jeanne A. Markey and Raymond M. Sarola Private equity, health care, and profits: It’s time to protect patients
Pharmalot By Ed Silverman Teva and Allergan reach $107 million deal with Rhode Island over opioid crisis
Pharmalot By Ed Silverman Dozens of towns and counties object to ‘hush money’ tied to Purdue opioid settlement
Pharmalot By Ed Silverman Mallinckrodt to pay $260 million to settle federal lawsuits over Medicaid rebates and kickbacks
First Opinion By Bret Mettler Sunsetting medical license reciprocity would return medicine to the dark ages